Clinical trials: Troponin I
Acute Coronary Syndrome, Acute Myocardial Infarction
Evaluation of a New Cardiac Biomarker Assay
The objective of the study is to evaluate the performance and intended use of a new cardiac biomarker test, Troponin I, in an intended use population.
- Trial name
- NCT01608100
- Testing
- ARCHITECT STAT High Sensitive Troponin I Assay
- Where
- 12 sites in United States
- Volunteers
- 1,101 people
- Sponsor
- Abbott Diagnostics Division
Chronic Heart Failure
Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure
This was a multicenter, randomized, double-blind, crossover, placebo-controlled, Phase II clinical study that evaluated the effect of serelaxin versus placebo (both in addition to SoC) on the release of hs-cTnI, in patients with…
- Trial name
- RELAX-Cardio (NCT02625922)
- Testing
- Serelaxin
- Where
- 9 sites in Germany, Switzerland and 1 more
- Volunteers
- 26 people
- Sponsor
- Novartis Pharmaceuticals